These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 29455665)

  • 1. PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.
    Haddadi N; Lin Y; Travis G; Simpson AM; Nassif NT; McGowan EM
    Mol Cancer; 2018 Feb; 17(1):37. PubMed ID: 29455665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.
    Carnero A; Blanco-Aparicio C; Renner O; Link W; Leal JF
    Curr Cancer Drug Targets; 2008 May; 8(3):187-98. PubMed ID: 18473732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K/PTEN signaling in tumorigenesis and angiogenesis.
    Jiang BH; Liu LZ
    Biochim Biophys Acta; 2008 Jan; 1784(1):150-8. PubMed ID: 17964232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis.
    Wang CG; Wang L; Yang T; Su SL; Hu YH; Zhong D
    Cytotherapy; 2020 Aug; 22(8):412-423. PubMed ID: 32561161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
    Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
    De Marco C; Laudanna C; Rinaldo N; Oliveira DM; Ravo M; Weisz A; Ceccarelli M; Caira E; Rizzuto A; Zoppoli P; Malanga D; Viglietto G
    PLoS One; 2017; 12(6):e0178865. PubMed ID: 28662101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.
    Chen CL; Tseng YW; Wu JC; Chen GY; Lin KC; Hwang SM; Hu YC
    Biomaterials; 2015 Mar; 44():71-81. PubMed ID: 25617127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between PI3K/AKT signalling pathway and cancer.
    Noorolyai S; Shajari N; Baghbani E; Sadreddini S; Baradaran B
    Gene; 2019 May; 698():120-128. PubMed ID: 30849534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells.
    Zhu G; Chai J; Ma L; Duan H; Zhang H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):526-31. PubMed ID: 23524257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.
    Lim HJ; Crowe P; Yang JL
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):671-89. PubMed ID: 25146530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
    Nozhat Z; Hedayati M
    Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
    Wang F; Li L; Chen Z; Zhu M; Gu Y
    Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI(3)king apart PTEN's role in cancer.
    Zhang S; Yu D
    Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering PI3K-Akt signalling in zebrafish embryos affects PTEN phosphorylation and gastrulation.
    Finkielsztein A; Kelly GM
    Biol Cell; 2009 Aug; 101(11):661-78, 4 p following 678. PubMed ID: 19515017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.